Stefano Rivella, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, shares some insights into a novel mouse model which has been developed for alpha-thalassemia, and has allowed researchers to better understand the pathophysiology of this disease and explore novel treatment approaches. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.